Clinical and pathologic differences in interstitial lung disease based on antisynthetase antibody type.

[1]  Ami A. Shah,et al.  Race and Association With Disease Manifestations and Mortality in Scleroderma , 2013, Medicine.

[2]  M. Rice,et al.  The Myositis Autoantibody Phenotypes of the Juvenile Idiopathic Inflammatory Myopathies , 2013, Medicine.

[3]  O. Benveniste,et al.  Clinical Heterogeneity and Outcomes of Antisynthetase Syndrome , 2013, Current Rheumatology Reports.

[4]  Nigel J Walker,et al.  Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. , 2012, Arthritis and rheumatism.

[5]  C. Oddis,et al.  Pulmonary manifestations of the idiopathic inflammatory myopathies. , 2010, Clinics in chest medicine.

[6]  N. Kaminski,et al.  Characterization and peripheral blood biomarker assessment of anti-Jo-1 antibody-positive interstitial lung disease. , 2009, Arthritis and rheumatism.

[7]  P Bélisle,et al.  Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences , 2008, Annals of the rheumatic diseases.

[8]  Jonathan G Goldin,et al.  High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease. , 2008, Chest.

[9]  L. Jorfeldt,et al.  Interstitial lung disease in polymyositis and dermatomyositis: longitudinal evaluation by pulmonary function and radiology. , 2008, Arthritis and rheumatism.

[10]  K. Nishimura,et al.  Prevalence of disease-specific antinuclear antibodies in general population: estimates from annual physical examinations of residents of a small town over a 5-year period , 2008, Modern rheumatology.

[11]  T. Nakazono,et al.  High-resolution computed tomography characterization of interstitial lung diseases in polymyositis/dermatomyositis. , 2008, The Journal of rheumatology.

[12]  Yue-ying Gu,et al.  Adult clinically amyopathic dermatomyositis with rapid progressive interstitial lung disease: a retrospective cohort study , 2007, Clinical Rheumatology.

[13]  D. Chung,et al.  Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. , 2005, Rheumatology.

[14]  G. Raghu,et al.  High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. , 2005, American journal of respiratory and critical care medicine.

[15]  T. Mimori,et al.  Immunogenetic features in 120 Japanese patients with idiopathic inflammatory myopathy. , 2004, The Journal of rheumatology.

[16]  A. Nicholson,et al.  Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis , 2004, Histopathology.

[17]  M. Hamidou,et al.  Le syndrome des antisynthétases , 2003 .

[18]  E. Hachulla,et al.  Interstitial lung disease in polymyositis and dermatomyositis. , 2002, Arthritis and rheumatism.

[19]  I. D. Johnston,et al.  American thoracic society/European respiratory society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias , 2002 .

[20]  D. Schroeder,et al.  Polymyositis-dermatomyositis-associated interstitial lung disease. , 2001, American journal of respiratory and critical care medicine.

[21]  Ò. Miró,et al.  Interstitial lung disease related to dermatomyositis. Comparative study with patients without lung involvement. , 1996, The Journal of rheumatology.

[22]  N. Rothfield,et al.  Sensitivity and specificity of anti-Jo-1 antibodies in autoimmune diseases with myositis. , 1996, Arthritis and rheumatism.

[23]  M. Arakawa,et al.  [Prognosis of interstitial pneumonitis (IP) in polymyositis (PM)/dermatomyositis (DM)]. , 1994, Ryumachi. [Rheumatism].

[24]  J. Hughes,et al.  Polymyositis, pulmonary fibrosis and autoantibodies to aminoacyl-tRNA synthetase enzymes. , 1990, The Quarterly journal of medicine.

[25]  E. Arsura,et al.  Adverse impact of interstitial pulmonary fibrosis on prognosis in polymyositis and dermatomyositis. , 1988, Seminars in arthritis and rheumatism.

[26]  F. Arnett,et al.  The Jo-1 antibody system in myositis: relationships to clinical features and HLA. , 1981, The Journal of rheumatology.

[27]  J. Hankinson,et al.  SERIES ''ATS/ERS TASK FORCE: STANDARDISATION OF LUNG FUNCTION TESTING'' Edited by V. Brusasco, R. Crapo and G. Viegi Number 4 in this Series Standardisation of the single-breath determination of carbon monoxide uptake in the lung , 2005 .

[28]  P. Leissner,et al.  Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county. , 1993, Neuroepidemiology.

[29]  A. Bohan,et al.  Polymyositis and dermatomyositis (second of two parts). , 1975, The New England journal of medicine.

[30]  A. Bohan,et al.  Polymyositis and dermatomyositis (first of two parts). , 1975, The New England journal of medicine.